142 related articles for article (PubMed ID: 18974104)
1. Just say no to ATOH: how HIC1 methylation might predispose medulloblastoma to lineage addiction.
Briggs KJ; Eberhart CG; Watkins DN
Cancer Res; 2008 Nov; 68(21):8654-6. PubMed ID: 18974104
[TBL] [Abstract][Full Text] [Related]
2. Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma.
Briggs KJ; Corcoran-Schwartz IM; Zhang W; Harcke T; Devereux WL; Baylin SB; Eberhart CG; Watkins DN
Genes Dev; 2008 Mar; 22(6):770-85. PubMed ID: 18347096
[TBL] [Abstract][Full Text] [Related]
3. Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma.
Stöcklein H; Smardova J; Macak J; Katzenberger T; Höller S; Wessendorf S; Hutter G; Dreyling M; Haralambieva E; Mäder U; Müller-Hermelink HK; Rosenwald A; Ott G; Kalla J
Oncogene; 2008 Apr; 27(18):2613-25. PubMed ID: 17982487
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the hypermethylated in cancer 1 tumour suppressor--not just a question of promoter hypermethylation?
Jenal M; Britschgi C; Fey MF; Tschan MP
Swiss Med Wkly; 2010; 140():w13106. PubMed ID: 21104471
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancreatic cancer.
Zhao G; Qin Q; Zhang J; Liu Y; Deng S; Liu L; Wang B; Tian K; Wang C
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S301-11. PubMed ID: 22552606
[TBL] [Abstract][Full Text] [Related]
6. HIC1 Represses Atoh1 Transcription and Hair Cell Differentiation in the Cochlea.
Abdul-Aziz D; Hathiramani N; Phung L; Sykopetrites V; Edge ASB
Stem Cell Reports; 2021 Apr; 16(4):797-809. PubMed ID: 33770497
[TBL] [Abstract][Full Text] [Related]
7. HIF1A is Overexpressed in Medulloblastoma and its Inhibition Reduces Proliferation and Increases EPAS1 and ATG16L1 Methylation.
Cruzeiro GAV; Dos Reis MB; Silveira VS; Lira RCP; Carlotti CG; Neder L; Oliveira RS; Yunes JA; Brandalise SR; Aguiar S; Eterovic AK; Tone LG; Scrideli CA; Valera ET
Curr Cancer Drug Targets; 2018; 18(3):287-294. PubMed ID: 28302031
[TBL] [Abstract][Full Text] [Related]
8. The Reelin receptors ApoER2 and VLDLR are direct target genes of HIC1 (Hypermethylated In Cancer 1).
Dubuissez M; Faiderbe P; Pinte S; Dehennaut V; Rood BR; Leprince D
Biochem Biophys Res Commun; 2013 Oct; 440(3):424-30. PubMed ID: 24076391
[TBL] [Abstract][Full Text] [Related]
9. Implication of HIC1 (Hypermethylated In Cancer 1) in the DNA damage response.
Dehennaut V; Leprince D
Bull Cancer; 2009 Nov; 96(11):E66-72. PubMed ID: 19822477
[TBL] [Abstract][Full Text] [Related]
10. [Chromosome arm 17p13.3: could HIC1 be the one ?].
Chopin V; Leprince D
Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
[TBL] [Abstract][Full Text] [Related]
11. Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma.
Brieger J; Pongsapich W; Mann SA; Hedrich J; Fruth K; Pogozelski B; Mann WJ
Oral Oncol; 2010 Sep; 46(9):678-83. PubMed ID: 20729134
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and diagnostic relevance of hypermethylated in cancer 1 (HIC1) CpG island methylation in renal cell carcinoma.
Eggers H; Steffens S; Grosshennig A; Becker JU; Hennenlotter J; Stenzl A; Merseburger AS; Kuczyk MA; Serth J
Int J Oncol; 2012 May; 40(5):1650-8. PubMed ID: 22327210
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma.
Rood BR; Zhang H; Weitman DM; Cogen PH
Cancer Res; 2002 Jul; 62(13):3794-7. PubMed ID: 12097291
[TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma.
Nakahara Y; Northcott PA; Li M; Kongkham PN; Smith C; Yan H; Croul S; Ra YS; Eberhart C; Huang A; Bigner D; Grajkowska W; Van Meter T; Rutka JT; Taylor MD
Neoplasia; 2010 Jan; 12(1):20-7. PubMed ID: 20072650
[TBL] [Abstract][Full Text] [Related]
15. Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development.
Lusher ME; Lindsey JC; Latif F; Pearson AD; Ellison DW; Clifford SC
Cancer Res; 2002 Oct; 62(20):5906-11. PubMed ID: 12384556
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma.
Fiaschetti G; Abela L; Nonoguchi N; Dubuc AM; Remke M; Boro A; Grunder E; Siler U; Ohgaki H; Taylor MD; Baumgartner M; Shalaby T; Grotzer MA
Br J Cancer; 2014 Feb; 110(3):636-47. PubMed ID: 24346283
[TBL] [Abstract][Full Text] [Related]
17. Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1.
Britschgi C; Rizzi M; Grob TJ; Tschan MP; Hügli B; Reddy VA; Andres AC; Torbett BE; Tobler A; Fey MF
Oncogene; 2006 Mar; 25(14):2030-9. PubMed ID: 16301995
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis.
Chen W; Cooper TK; Zahnow CA; Overholtzer M; Zhao Z; Ladanyi M; Karp JE; Gokgoz N; Wunder JS; Andrulis IL; Levine AJ; Mankowski JL; Baylin SB
Cancer Cell; 2004 Oct; 6(4):387-98. PubMed ID: 15488761
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification.
Svedlund J; Koskinen Edblom S; Marquez VE; Åkerström G; Björklund P; Westin G
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1307-15. PubMed ID: 22544915
[TBL] [Abstract][Full Text] [Related]
20. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
